TC-E 5008

TC-E 5008 is a potent and selective small molecule inhibitor targeting mutant isocitrate dehydrogenase 1 (mIDH1) . It is a valuable research tool for investigating mIDH1-driven mechanisms in cancers such as glioma and acute myeloid leukemia, supporting both in vitro and in vivo studies.